Every material Form 8-K MetLife filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
MetLife reported third quarter 2024 net income of $1.3 billion, or $1.81 per share, up from $422 million a year earlier, driven mainly by net derivative gains. Adjusted earnings fell 8 percent to $1.4 billion, or $1.95 per share, and adjusted premiums, fees and other revenues declined 5 percent, so shareholders see a mixed picture of reported profit gains alongside weaker core measures.
Net income was $1.3 billion ($1.81 per share) versus $422 million ($0.56 per share) in Q3 2023, mainly from net derivative gains of $767 million.
Adjusted earnings were $1.4 billion ($1.95 per share), down 8 percent in dollars and 1 percent per share from $1.97 a year earlier.
Adjusted premiums, fees and other revenues fell 5 percent to $12.5 billion, while adjusted net investment income rose 2 percent to $5.1 billion.
Book value per share rose 33 percent to $39.02; holding company cash and liquid assets were $4.5 billion at September 30, 2024.
MetLife reported second quarter 2024 net income of $912 million, or $1.28 per share, up from $370 million, or $0.48 per share, a year earlier. Adjusted earnings rose 9 percent to $1.6 billion, or $2.28 per share, while premiums, fees and other revenues were essentially flat at $13.5 billion. For shareholders, the higher earnings are offset in part by book value per share, which fell 5 percent to $33.30.
Net income of $912 million, or $1.28 per share, versus $370 million, or $0.48 per share, in Q2 2023
Adjusted earnings of $1.6 billion, or $2.28 per share, up 18 percent per share from $1.94
Book value per share of $33.30, down 5 percent from $34.92 at June 30, 2023
Group Benefits adjusted earnings rose 43 percent to $533 million
At its June 18, 2024 annual meeting, MetLife shareholders elected 13 directors, ratified Deloitte & Touche LLP as auditor for 2024, and approved the MetLife, Inc. 2025 Stock and Incentive Compensation Plan, effective January 1, 2025. Shareholders did not approve a shareholder proposal requesting a third-party racial equity audit, and they approved the named executive officer compensation on an advisory basis.
Stock plan approved with 582,251,541 votes for and 21,677,385 against; the plan covers equity grants to employees, executive officers and non-management directors.
Shareholder racial equity audit proposal failed, with 99,437,619 votes for and 501,548,093 against.
Deloitte & Touche LLP ratified as independent auditor for 2024 with 615,941,976 votes for and 32,282,137 against.
The Board also approved the MetLife Annual Variable Incentive Plan on June 18, 2024, for performance periods beginning on or after January 1, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every MetLife filing is on SEC EDGAR ↗. 8-K briefs of other companies →